baber/WOPTO huggingface dataset:
Patent NZ-584270-A (NZ)
Title: Light fixture support system comprising a bracket and slideway on attachment member
Inventor: KINNUNE BRIAN L
IPC: F21V21/02
Filed: 2008-05-02
Abstract: A ceiling-mounted light-fixture support assembly is disclosed comprising a mounting bracket (12) and a fixture attachment member (14). The mounting bracket (12) has side flanges (30, 32) extending from each side that are offset from a lower surface (opposite upper surface 18) and the width of the mounting bracket (12) is the combined width of the bracket and the side flanges (30, 32). The fixture attachment member (14) has a top defining an opening which has a width narrower than the mounting bracket (12). The fixture attachment member (14) further has a recessed slideway (56) which (a) is in lateral communication with the top opening, (b) has a width wider than the mounting bracket (12), and (c) is spaced sufficiently lower than the top to receive the two side flanges (30, 32) of the mounting bracket (12). The fixture attachment member (14) can be initially positioned within the slideway (56) and then repositioned to be mounted within the top opening to support a light fixture.
Patent NZ-588700-A (NZ)
Title: Inhibitors of phosphatidylinositol 3-kinase (pi3k)
Inventor: WANG TIANSHENG
IPC: A61K31/4365
Filed: 2009-04-14
Abstract: Provided are inhibitors of phosphatidylinositol 3-kinases with formula (I) as depicted, with defined substituents. The compounds are useful for lessening the severity of a disease or condition selected from an autoimmune disease or an inflammatory disease of the brain or spinal cord.
Patent NZ-588709-A (NZ)
Title: Antioxidant inflammation modulators: triterpenoid oleanolic acid derivatives with saturation in the c-ring
Inventor: ANDERSON ERIC
IPC: A61K31/56
Filed: 2009-04-20
Abstract: Disclosed are oleanane derivative compounds of Formula (I) and methods for their preparation. Specific examples of compounds of Formula (I) include: (4aS,6aR,6bR,8aR,12aR,14aR,14bS)-methyl 11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,12b,13,14,14a,14b-icosahydropicene-4a-carboxylate, (4aS,6aR,6bR,8aR,12aR,12bR,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-N-(2,2,2-trifluoroethyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,12b,13,14,14a,14b-icosahydropicene-4acarboxamide, and (4aR,6aR,6bS,8aS,12aR,12bR,15aR,15bR)-methyl 2-cyano-4,4,6a,6b,11,11,15b-heptamethyl-3,14-dioxo-4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,15,15a,15b-icosahydro-3H-dinaphtho[1,2-b:2',1'-d]azepine-8a-carboxylate. Compounds of Formula (I) have antioxidant and anti-inflammatory properties and are useful to: treat cancer, treat or prevent a disease with an inflammatory component, treat or prevent a cardiovascular disease, treat or prevent a neurodegenerative disease, improve glomerular filtration rate or creatinine clearance, inhibit IFN-g-induced nitric oxide production in cells treat or prevent a disorder characterized by overexpression of COX-2 genes, or treat renal/kidney disease (RKD).
Patent NZ-589042-A (NZ)
Title: Gland for sealed termination of armoured cable conduit
Inventor: CLOKE KEVIN
IPC: H02G3/06
Filed: 2010-11-05
Abstract: Disclosed is a gland for exiting a cable from an enclosure in a hazardous environment providing improved sealing and safety. The gland includes an enclosure engaging portion, and a conduit engaging portion for engaging an armoured conduit to resist rough handling of the armoured conduit. The enclosure engaging portion includes a first tubular body for carrying the cable, a mounting at one end of the first tubular body for sealingly engaging an aperture in the enclosure to mount the enclosure engaging portion and to impede or prevent gases escaping from the enclosure to an exterior of the tubular body. A seal within the first tubular body sealingly engages the cable to substantially impede or prevent gases escaping from the enclosure through the tubular body. The conduit engaging portion includes an externally threaded tubular boss for threadingly engaging an interior of the armoured conduit, when engaged with the armoured conduit, is attachable to the enclosure engaging portion when the enclosure engaging portion is so mounted by hand without rotation of the conduit.
Patent NZ-591887-A (NZ)
Title: Device for in-cup-preparation of a beverage with two nozzles directed to the bottom aof a receptacle and two nozzles directed to the side wall
Inventor: BERGDAHL JOHAN
IPC: A47J31/46
Filed: 2009-09-22
Abstract: A beverage production device and method is disclosed for preparing a beverage from concentrate contained in a receptacle (13). The device includes a support means (1) for supporting the receptacle (13) and a plate member (2) arranged vertically to the support means (1). The plate member (2) comprises at least four outlet nozzles (4) and a liquid supply means connected to the nozzles for injecting a fluid jet (A1 - A4) into the receptacle (13). At least two of the outlet nozzles are designed to direct a fluid jet (A3, A4) to an inner side wall (13b) of the receptacle at different angles with respect to the vertical. At least two further outlet nozzles are designed to direct a fluid jet (A1, A2) to the bottom (13a) of the receptacle at different angles with respect to the vertical.
Patent NZ-592271-A (NZ)
Title: Actuator controller with position sensor to sense actuator position and control to move to a desired position
Inventor: MATTES JOHN
IPC: A61G5/10
Filed: 2006-08-31
Abstract: Disclosed is an actuator controller for closed-loop control of one of a plurality of seat and leg support position actuators of a wheelchair. The actuator controller comprises: a controller (70) which receives a desired actuator position signal from a communication bus of the wheelchair; an actuator driver circuit (82) responsive to control signals from the controller (70) to drive the position actuator; and a position sensor circuit (80) for receiving an actuator position signal. The controller (70) reads the actuator position signal and performs closed-loop control of the position actuator using the actuator driver circuit (82) based on the desired and read actuator position signals. The actuator controller further comprises an indicator to communicate sensor type data associated with the position sensor to the controller (70), which renders actuator position data from the actuator position signal.
Patent NZ-594227-A (NZ)
Title: Compositions of surface modified nanoparticles
Inventor: IVERSON ISAAC KEENE
IPC: C09D7/62
Filed: 2010-02-02
Abstract: 594227 Disclosed is a composition comprising an aqueous dispersion offluoroalkylsilyl surface modified nanoparticles, wherein the nanoparticles comprise at least one member selected from the group consisting of silica, titania, zirconia, layered magnesium silicate, alumina silicate, natural clay, synthetic clay and mixtures thereof, and wherein the fluoroalkylsilyl is: (F(CF2)nCH2CH2)mSi(O-)p, where n is 2,3 or 4, where p is 1,2 or 3, where m is (4-p), and wherein volatile organic solvents are absent. Also disclosed is a process for making the nanoparticles, a substrate modified by the nanoparticle composition, a process of modifying a substrate with the nanoparticle composition and an article made out of the substrate.
Patent NZ-597434-A (NZ)
Title: Closure for a container
Inventor: MAYERS JEFFREY
IPC: B65D41/04
Filed: 2010-07-30
Abstract: A closure for a container, and a container incorporating the same, that minimizes or eliminates leakage between the closure and the container holding the liquid. The closure provides a liquid sealing system that allows irregularly shaped closure tops to be used without sacrificing the effectiveness of the liquid seal. In one embodiment, the closure (20) includes a plurality of struts (70) disposed within an annular space that receives a neck portion of the container to create a seating plane that corresponds to a plane (P) formed by the rim of the neck portion.
Patent NZ-597993-A (NZ)
Title: Process for the continuous manufacture of a polyisobutylene based transdermal patch
Inventor: BAIRD RUSSELL ADAM
IPC: A61K9/70
Filed: 2010-07-19
Abstract: Disclosed herein is a solvent free process for the production of an adhesive composition comprising: feeding high molecular weight polyisobutylene (HWM PIB) into an extruding apparatus, wherein said high molecular weight polyisobutylene is substantially free of fillers, solvents and plasticizers; mixing said HMW PIB with low molecular weight polyisobutylene (LMW PIB) in said extruding form a melt substantially free of fillers, plasticizers; apparatus to solvents and adding an active pharmaceutical ingredient (API) to said melt to produce an API/PIB melt; and discharging said API/PIB melt to a die to form said adhesive composition substantially free of fillers, solvents and plasticizers.
Patent NZ-609155-A (NZ)
Title: Zinc oxide nanostructures
Inventor: KENNEDY JOHN VEDAMUTHU
IPC: C01G9/03
Filed: 2009-04-14
Abstract: Disclosed is a method for producing zinc oxide nanostructures, the method comprising: providing a zinc anode and a cathode in an arc discharge chamber, wherein the cathode is arranged horizontally in the arc discharge chamber and the anode is arranged vertically; supplying current to the anode and the cathode to establish an arc discharge between the cathode and the anode to vaporise the anode and produce the zinc oxide nanostructures; terminating the current supply to the anode and the cathode; and collecting the resulting zinc oxide nanostructures. Also disclosed is a method for producing a sensor component, the method comprising: providing a sensor substrate comprising a conducting thin film at least partially covering at least two regions on at least one surface of a sensor substrate material to define a gap in the conducting thin film; applying a mixture comprising zinc oxide nanostructures and a nonionic polymer to at least a portion of the gap in the conducting thin film and thereby bridge the gap; and optionally, annealing the mixture of zinc oxide nanostructures and nonionic polymer applied to the sensor substrate, to provide the sensor component. Further disclosed is a sensor component comprising: a sensor substrate comprising a conducting thin film at least partially covering at least two regions on at least one surface of a sensor substrate material to define a gap in the conducting thin film; and a mixture comprising zinc oxide nanostructures and a nonionic polymer covering at least a portion of the gap in the conducting thin film, thereby bridging the gap.
Patent NZ-614488-A (NZ)
Title: Window stay, window systems and mounting methods
Inventor: BROWNLIE SUSAN MYRTLE
IPC: E05C17/00
Filed: 2012-08-31
Abstract: 614488 A window stay 1 has a frame plate 2 and a sash plate 3 interconnected by pivoting links 4,5. Frame plate 2 has a projection 14 that will engage in a complementary aperture in an adjoining part of a window frame (not shown). This enables preliminary attachment of the stay with window so that an installer can complete the fixing of screws to fasten the frame plate 2 to the adjacent parts of the window frame.
Patent NZ-627995-A (NZ)
Title: ß-arrestin effectors and compositions and methods of use thereof
Inventor: CHEN XIAO-TAO
IPC: A61K38/04
Filed: 2013-01-30
Abstract: Disclosed is a peptide or peptide mimetic comprising the sequence of Sar-Zz-Val-Aa-Xx-His-Bb-Yy (SEQ ID NO: 25), wherein: - Zz is Arg or Met; - Aa is Tyr or D-Cys; - Xx is Pro, cyHex, cyPen, AA01, AA02, or AA03; - Bb is Pro, Cys, Pro-NH-iPr, Pro-NH-neopentyl, Pro-NH-Et, or Pro-NH-Me; - Yy is any amino acid residue, D-Ala, 2-amino-2-methylpropanoic acidAA01, (2S)-2-amino-3,3-dimethylbutanoic acid AA02, (2S)-2-amino-3-hydroxy-3-methylbutanoic acid, or null, provided that the peptide or peptide mimetic is not SEQ ID NO: 4. Also disclosed is a method of treating cardiovascular disorders comprising administering to a subject or subject in need thereof a therapeutically effective amount of the above-described peptide, the cardiovascular disorder to be treated includes chronic hypertension, hypertensive crisis, acute congestive heart failure, angina, acute myocardial infarction, left ventricular failure, cerebrovascular insufficiency, intracranial haemorrhage, heart failure, acute decompensated heart failure, essential hypertension, post-operative hypertension, hypertensive heart disease, hypertensive renal disease, renovascular hypertension, malignant hypertension, post-renal transplant patient stabilization, dilated cardiomyopathy, myocarditis, post-cardiac transplant patient stabilization, disorders associated with post-stent management, neurogenic hypertension, pre-eclampsia, abdominal aortic aneurysm, or any cardiovascular disorder with a hemodynamic component. Also disclosed is a method of treating a viral infectious disease linked to AT1R comprising: administering to a subject or subject in need thereof a therapeutically effective amount of the above-described peptide.
Patent NZ-631481-A (NZ)
Title: Pool maintenance
Inventor: WALLACE PETER RONALD
IPC: G08C25/00
Filed: 2014-09-12
Abstract: A system for controlling multiple parameters of an outdoor swimming pool or spa, e.g. chlorination, filtration, temperature etc., by a mobile telecommunication device. The device (a tablet or mobile phone or other device) automatically sends a signal to the pool controller regarding the weather e.g. warning of an approaching storm or other meteorological phenomenon, and adjusts the parameters accordingly.
Patent NZ-707133-A (NZ)
Title: Conductive yarn and apparatus for making the same
Inventor: CHI-HSUEH RICHARD
IPC: H05B3/34
Filed: 2015-04-20
Abstract: A conductive yarn 3 and an apparatus for making the same, more particularly a fine metal thread 2 is wound around a core thread 1 in a spiral form via the apparatus to form the conductive yarn 3 capable of generating heat and used for manufacturing a fabric. Wherein the fabric is made of a plurality of conductive metal wires 6 in a warp direction, which are located only adjacent to two side margins of the fabric in 0.5 to 0.6 centimeters, a plurality of non-conductive threads 5 only in the warp direction, which are limited to the middle part of the fabric, and a plurality of conductive yarns 3 in a weft direction, whereby the metal threads of the conductive yarn 3 are interlaced with the conductive metal wires 6 of the warp direction to form a well-conductive fabric; and wherein the diameter of the conductive metal wire 6 ranges from 0.05 to 0.12 mm; and wherein the diameter of the fine metal thread 2 ranges from 0.02 to 0.12 mm; and wherein the fine metal thread 2 wound around the non-conductive core thread 1 is wound at 70 to 125 coils per centimeter of the non-conductive core thread 1.
Patent NZ-716236-A (NZ)
Title: A swimming pool pump
Inventor: PALMER ROSS LESLIE
IPC: F04D15/00
Filed: 2012-08-10
Abstract: The invention resides in a swimming pool pump (110) which is able to operate at a low speed and a high speed, the pump (110) automatically switched between the low speed and the high speed each time power is supplied to the pump.
Patent NZ-719420-A (NZ)
Title: Cmp-containing, high protein denatured whey protein compositions, products containing them, and uses thereof
Inventor: BERTELSEN HANS
IPC: A23J1/20
Filed: 2014-10-23
Abstract: The present invention pertains to CMP-containing, high protein denatured whey protein compositions and to a method of producing them. The invention furthermore pertains to products containing the high protein denatured whey protein compositions, particularly high protein, acidified dairy products, and additional uses of the denatured whey protein compositions.
Patent NZ-720939-A (NZ)
Title: Touch sensitive control system for non-electronic display substrate surfaces
Inventor: MATTHEW JOHN VAN DER WERFF
IPC: G06F3/045
Filed: 2016-06-22
Abstract: This invention relates to a touch sensitive control system capable of providing touch activated control for use on non-electronic devices including walls, flooring, doors, furniture, cabinetry, and vehicles. The present system is capable of responding to different touch sequences and touch locations over a large area to control electrical devices. The touch sensitive system is achieved through providing an electrically active layer capable of capacitive, resistive or time-of-flight sensing together with an electronic controller configured to detect a differentiated touch selected from: one or more of multiple sequential touches, one or more touches of extended duration, or a combination of these.
Patent NZ-723827-A (NZ)
Title: A method of manufacturing a stabilised complex of corticotropin releasing hormone (crh) and alpha-2 macroglobulin
Inventor: MCINTOSH DEIRDRE PATRICIA
IPC: A61P31/14
Filed: 2013-03-05
Abstract: The present invention relates to a CRH formulation having improved stability / efficacy. The improved CRH formulation is particularly suitable for treatment of various disorders. The invention also or alternatively relates to a method of producing the CRH formulation. In a particular embodiment, the invention relates to a method of manufacturing a stabilised complex of corticotropin releasing hormone (CRH) and alpha-2 macroglobulin, the method comprising: (a) providing hyperimmune serum from an ungulate that has been immunised with an immunodeficiency virus; (b) subjecting said hyperimmune serum to a microfiltration step that removes molecules having a size greater than 0.2 microns, thereby providing a micro-filtered serum; (c) subjecting said micro-filtered serum to a nanofiltration step that removes molecules having a size greater than 35 nanometres, thereby providing a nano-filtered serum; (d) aliquoting said nano-filtered serum into a vial, wherein said nano-filtered serum is in a form for administration to a patient and comprises the stabilised complex of CRH and alpha-2 macroglobulin; wherein the serum remains unfrozen throughout steps (b) to (d). The present invention also or alternatively relates to methods of treatment using said CRH formulation.
Patent NZ-724923-A (NZ)
Title: Crystalline forms of grapiprant
Inventor: SMITH MELISSA
IPC: C07D487/04
Filed: 2015-03-05
Abstract: The present disclosure provides a crystalline form of grapiprant selected from the group consisting of Form X, Form X2, Form X3, Form F, Form K, Form L, Form M, and Form N. Also provided is a pharmaceutical composition, the composition comprising at least one crystalline form of grapiprant, and at least one pharmaceutically acceptable excipient, wherein the crystalline form of grapiprant is selected from the group consisting of Form X, Form X2, Form X3, Form F, Form K, Form L, Form M, and Form N. Other aspects of the disclosure provide a process for preparing a substantially pure crystalline Form A of grapiprant. The process comprises contacting grapiprant at ambient temperature with a solvent comprising dichloromethane and acetone to form a saturated or a near saturated solution. Crystals of the substantially pure crystalline Form A of grapiprant are formed.
Patent NZ-733404-A (NZ)
Title: External ear canal pressure regulation system
Inventor: GEORGE DAVID
IPC: A61M13/00
Filed: 2014-06-27
Abstract: Pain or discomfort associated with a disorder, including neurologically-mediated disorders such as craniofacial pain syndromes or headache syndromes, may negatively impact the quality of life of the sufferer. In addition to the burden upon the individual, chronic neurological conditions may be a significant strain upon family members, employers, and the healthcare system. There would be a substantial advantage in providing a device or methods which can generate one or more stimuli which can alleviate one or more symptoms associated with a disorder, such as craniofacial pain syndromes or headache syndromes, or treat one or more disorders. An external ear canal pressure regulation device comprises a first fluid flow generator capable of generating a first fluid flow; a first earpiece having a first earpiece axial conduit which communicates between first earpiece first and second ends, said first earpiece axial conduit fluidicly coupled to said first fluid flow generator, said first earpiece having a first earpiece compliant external surface configured to sealably engage a first external ear canal of a first ear as a first barrier between a first external ear canal pressure and an ambient pressure, said first fluid flow generator capable of generating a first pressure differential between said first external ear canal pressure and said ambient pressure, said first pressure differential comprising a first pressure differential amplitude; a first pressure sensor which generates a first pressure sensor signal which varies based upon change in a first pressure differential amplitude; and a first pressure signal analyser. The first pressure signal analyser comprises a first pressure differential amplitude comparator which compares a preselected first pressure differential amplitude to said first pressure differential amplitude, said first pressure sensor signal analyser generating a first pressure differential amplitude compensation signal to which a first fluid flow generator controller is responsive to control said first fluid flow generator to achieve said pre-selected first pressure differential amplitude.
Patent NZ-736293-A (NZ)
Title: Method and apparatus for forming a package comprising a stack of absorbent tissue paper material and a packaging
Inventor: WALLENIUS HANS
IPC: A47K10/16
Filed: 2015-06-22
Abstract: A method for forming a package (100) comprising a stack (10) of absorbent tissue paper material and a packaging (20). The tissue paper material forms panels having a length (L), and a width (W), the panels being stacked to form a height (H). The packaging encircling the stack maintains it in a compressed condition, with a selected packing density D0, and a selected packing height H0. The tissue paper material is a dry crepe material, and the selected packing density D0 is between 0.30 and 0.95 kg/dm3. Alternatively, the tissue paper material is a structured tissue material, and the selected packing density D0 is between 0.20 and 0.75 kg/dm3. Alternatively, the tissue paper material is a combination material, comprising at least a dry crepe material and at least a structured tissue material, and the selected packing density D0 is between 0.25 and 0.80 kg/dm3. The method comprises: forming the stack tissue paper material; compressing each portion of said stack in a direction along the height (H) to assume a temporary height H1 being c1 x H0, where c1 is between 0.30 and 0.95; and applying the packaging to the stack. The method allows compression of a stack of absorbent tissues to a level that maintains tissue paper quality, while reducing the force exerted on the packaging material. This provides an advantage over previous compression methods which can impair the quality of the product and/or exert large springback forces, which pose problems when packaging & opening.